Abrdn Healthcare Investors (NYSE:HQH) Hits New 12-Month High at $18.60

Abrdn Healthcare Investors (NYSE:HQH)’s share price hit a new 52-week high during trading on Monday . The company traded as high as $18.60 and last traded at $18.57, with a volume of 69322 shares. The stock had previously closed at $18.18.

Abrdn Healthcare Investors Stock Up 2.1 %

The business has a fifty day moving average of $17.15 and a 200 day moving average of $16.93.

Abrdn Healthcare Investors Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Thursday, May 23rd were paid a $0.59 dividend. The ex-dividend date was Wednesday, May 22nd. This is a boost from Abrdn Healthcare Investors’s previous quarterly dividend of $0.48. This represents a $2.36 dividend on an annualized basis and a dividend yield of 12.72%.

Hedge Funds Weigh In On Abrdn Healthcare Investors

A number of hedge funds and other institutional investors have recently made changes to their positions in HQH. Cornerstone Advisors LLC boosted its holdings in shares of Abrdn Healthcare Investors by 66.7% in the fourth quarter. Cornerstone Advisors LLC now owns 732,299 shares of the financial services provider’s stock valued at $12,134,000 after buying an additional 292,920 shares during the period. RPO LLC boosted its stake in Abrdn Healthcare Investors by 1.5% in the 4th quarter. RPO LLC now owns 382,486 shares of the financial services provider’s stock worth $6,338,000 after purchasing an additional 5,695 shares during the period. Raymond James Financial Services Advisors Inc. increased its holdings in Abrdn Healthcare Investors by 5.8% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 252,971 shares of the financial services provider’s stock worth $4,192,000 after purchasing an additional 13,816 shares in the last quarter. Quantedge Capital Pte Ltd raised its stake in shares of Abrdn Healthcare Investors by 42.5% in the 4th quarter. Quantedge Capital Pte Ltd now owns 209,600 shares of the financial services provider’s stock valued at $3,473,000 after purchasing an additional 62,500 shares during the period. Finally, Cetera Investment Advisers lifted its holdings in shares of Abrdn Healthcare Investors by 46.8% in the first quarter. Cetera Investment Advisers now owns 177,208 shares of the financial services provider’s stock valued at $2,988,000 after purchasing an additional 56,521 shares in the last quarter. 32.60% of the stock is owned by institutional investors.

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.